| Followers | 834 |
| Posts | 119891 |
| Boards Moderated | 17 |
| Alias Born | 09/05/2002 |
Thursday, March 04, 2010 7:22:34 PM
These photos of a metastatic melanoma patient improving on ipilimumab
are so graphic that BMY opted to exclude them from the slide set at today’s
investor presentation. Note the delay between the start of treatment
and the onset of observable improvement, which is the trademark
pattern in immuno-oncology. At 12 weeks, the lesions are worse than at
baseline, but four weeks later—at 16 weeks—they are vastly improved.
are so graphic that BMY opted to exclude them from the slide set at today’s
investor presentation. Note the delay between the start of treatment
and the onset of observable improvement, which is the trademark
pattern in immuno-oncology. At 12 weeks, the lesions are worse than at
baseline, but four weeks later—at 16 weeks—they are vastly improved.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
